Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Status

Recruiting

NCT ID

NCT05557877

This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) women planning to have a breast biopsy. Chronic inflammation may increase the risk of postpartum related breast cancer. Low-dose aspirin is a non-steroidal anti-inflammatory drug. Giving low-dose aspirin may affect markers of inflammation in blood and tissue and may prevent postpartum related breast cancer.

Intervention

Biopsy, Biospecimen Collection, Low-Dose Aspirin, Questionnaire Administration

Condition

Breast Carcinoma

Investigators

Kathryn J. Ruddy, M.D., Clinical Trials Referral Office, Barbara A. Pockaj, M.D., Jessica M, Tarah Ballinger, MD

See list of participating sites